Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBLINGUALStandard

NITROMIST

NITROGLYCERIN

Standard Dose
0.4MG/SPRAY
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NITROMIST is listed in Drugs@FDA under application 021780 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient NITROGLYCERIN Form and strength AEROSOL, METERED;SUBLINGUAL - 0.4MG/SPRAY Sponsor EVUS Submission history Latest submission status date: 2022-06-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview NITROMIST is listed in Drugs@FDA under application 021780 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NITROGLYCERIN Form and strength AEROSOL, METERED;SUBLINGUAL - 0.4MG/SPRAY Sponsor EVUS Submission history Latest submission status date: 2022-06-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.